MOZARC
LIVE

Serial Number

97741276

Owner

Mozarc Medical US LLC

Attorney

Sang Eun Lee

Filing Date

Jan 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MOZARC Trademark

Serial Number: 97741276

MOZARC is a trademark filed by Mozarc Medical US LLC on January 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Mozarc Medical US LLC

710 Medtronic Parkway
Minneapolis, MN 55432

Entity Type: 16

Trademark Details

Filing Date

January 4, 2023

Registration Date

Not Registered

Published for Opposition

January 30, 2024

Goods & Services

Dialysis machines; medical instruments and apparatus for purification and filtration of blood; medical apparatus and instruments being hemodialysis apparatus for the treatment of kidney failure; dialysis equipment and parts therefor, comprised of dialysis machines, consoles, sorbent rechargers, dialyzers, filters, and sorbent cartridges sold as a unit; kidney dialysis equipment for peritoneal dialysis, hemodialysis, hemodiafiltration, ultrafiltration, and accessories therefor for use in a home or clinical setting, namely, dialysis machines and disposables for use in dialysis machines, cassettes, tubing sets, tubing and empty containers sold as a unit; computerized electrolyte analyzers being medical diagnostic apparatus for analyzing and measuring electrolytes in the body; blood cell separating medical machines for the purpose of separating human blood components for use in blood transfusions sold as a unit with replacement components, and medical fibers; tubing systems comprised of tubing for use with catheters, blood lines being blood tubing sets for medical purposes, sold empty, needles for medical use, biopsy valves, luer lock caps for medical use, biopsy valves, catheters, catheter adapters, clamps for surgical use, cones being medicinal catheters for dialysis machines; containers for solutions used for the treatment of kidney disease, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use; dialyzers; blood filtration apparatus being blood transfusion apparatus; plasma filtrations apparatus being plasma component separation apparatus for medical purposes and medical and fibers sold as a unit; medical devices and apparatus used to filter fluids and wastes from a patient's blood; filters for blood and blood components for medical purposes; medical instruments for use in dialysis, namely, surgical catheters; catheters and parts and fittings therefor; and tubing for use with catheters and dialyzers; medical image processors

Computer, data processors, and downloadable mobile device computer software incorporating algorithms used to manage, control, operate and display information from medical devices for the treatment of organ deficiencies, medical devices for renal and extra-renal therapies, medical devices for filtration of bodily fluids and plasma exchanges, dialysis machines, and blood filtering devices; downloadable computer software using artificial intelligence for use in machine learning, both supervised and unsupervised for managing and monitoring kidney prescriptions; cloud infrastructure being downloadable cloud-computer software and related downloadable management software to manage patient prescriptions and ordering of consumables, kits comprised of RFID transponders, troubleshooting service, and maintenance of equipment related to patient prescriptions; electronic identification apparatus and instruments for dialysis equipment, namely, Radio Frequency Identification and Distribution (RFID) apparatus and instruments, namely, transceivers, transmitters, receivers, readers, antennas and reader management equipment being card reading equipment, RFID transponders, RFID tags and RFID evaluation kits comprised of RFID readers and antennas for dialysis equipment, and consumables being pipette tips

Pharmaceutical solutions used in dialysis; fluids for peritoneal or parenteral administration, namely, dextrose being glucose in water, dextrose being glucose and sodium chloride in water, dextrose being glucose and vitamins, dextrose being glucose and combinations of sodium chloride, magnesium chloride, calcium chloride, and sodium lactate all for medical purposes; pharmaceutical solutions used in dialysis containing vitamins, water, protein, osmotic agents; sterile, non-pyrogenic fluids for use in solutions to be administered parenterally for medical purposes; sugars in water for medical purposes; fluids for use in dialysis containing any amount of icodextrin or polyglucose for medical purposes; medical preparations for use in dialysis containing pharmaceuticals

Provision of temporary use of online, non-downloadable mobile device software incorporating algorithms used to manage, control, operate and display information from medical devices for the treatment of organ deficiencies, medical devices for renal and extra-renal therapies, medical devices for filtration of bodily fluids and plasma exchanges, dialysis machines, and blood filtering devices; providing a website featuring online, non-downloadable software using artificial intelligence for use in machine learning, both supervised and unsupervised for managing and monitoring kidney prescriptions; provision of temporary use of online, non-downloadable cloud infrastructure being cloud-computer software and related online, non-downloadable management software to manage patient prescriptions and ordering of consumables, kits comprised of RFID transponders, troubleshooting service, and maintenance of equipment related to patient prescriptions

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 27, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 21, 2025 EXRA
SOU EXTENSION 3 GRANTED
Aug 19, 2025 EX3G
SOU EXTENSION 3 FILED
Aug 19, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 11, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 11, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 3, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 3, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 3, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 25, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2023 NWOS
NEW APPLICATION ENTERED
Jan 7, 2023 NWAP